IGF‑1 LR3 1mg is our extended-sequence analogue of insulin‑like growth factor‑1, configured to provide improved stability and experimental flexibility in cell-based research. Its modified structure supports prolonged activity in vitro, making it a practical choice for studies of cell growth, survival, and differentiation.

Researchers utilise IGF‑1 LR3 in assays probing receptor binding, downstream signalling cascades, and interactions with growth factor networks in tissue culture. The 1mg format is ideal for high-precision work, dose - response mapping, and pilot projects where tight control of concentration and exposure is essential.

We supply this peptide with research-grade specifications and make COAs available on request, supporting rigorous, reproducible work in molecular and cellular biology.

Disclaimer: For scientific research use only. Not for human or animal use or consumption.